ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

55 hedge funds and large institutions have $10M invested in Oncternal Therapeutics, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

51% less call options, than puts

Call options by funds: $139K | Put options by funds: $284K

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$139K
Puts
$284K
Net Calls
Net Calls Change

Top Buyers

1
+$302K
2
+$294K
3
+$182K
4
BA
BlackRock Advisors
Delaware
+$148K
5
ProShare Advisors
ProShare Advisors
Maryland
+$41K

Top Sellers

1
-$805K
2
-$202K
3
-$188K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$168K
5
WMSA
Weiss Multi-Strategy Advisers
New York
-$100K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$5K
52
$3.15K
53
$3K
54
$2K
55
$3
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
1 2
3